Epidemiological Distribution of High Risk Human Papillomavirus Genotype and Associated Factors of HPV Infection with Cervical cancer in The Female aged 30-60 Years at Roi-ET Province

Authors

  • Jaruwan Pradittapong Roi-Et Provincial Public Health Office

Keywords:

Prevalence, Genotype Human Papillomavirus, Risk factors, Cervical cancer

Abstract

Cervical cancer is the second most common cancer affecting Thai women. Human papilloma virus (HPV) is the most viral sexually transmitted infection of the reproductive tract, and cervical cancer is the most common HPV-related disease. Therefore, the objective of this study was to determine the prevalence of HPV infection and risk factors associated with infection among women attending the cervical cancer screening. This was a cross-sectional study from Roi-Et hospital were selected and 377 women aged 30-60 years old were invited to participate in cervical cancer screening by both cytology and HPV testing. Sociodemographic data were collected using a self-administered questionnaire. Multivariate analyses were performed to assess the factors associated with HPV infection at p-value 0.05.

The result found that HPV genotype were classified as low risk (LR) and high risk (HR) by nucleotide sequencing. In total, 59.7 (225/377) of the participants had HPV-DNA, and HR-HPV was the most prevalent type 16,18 (34.8%), LR-HPV 29.8% respectively. Furthermore, age at first sexual, number of sexual partners, history of contraception, and history of alcohol consumption were statistically significantly associated with HPV infection (p-value < 0.05). Conclusion: The prevalent of HPV was high in married women, and especially in women who had normal cytology result, which suggests the need for greater screening for HPV infection in women’s primary health care.

References

ดุริยา ฟองมูล,และคณะ.(2558).ความชุกและการกระจายตัวของการติดเชื้อไวรัสฮิวแมนแปปปิโลม่าชนิดความเสี่ยงสูงในโรงพยาบาลมะเร็งลำปาง. วารสารเทคนิคการแพทย์เชียงใหม่, 48(3), 231- 240.

ทุมวดี ตั้งศิริวัฒนา, และคณะ.(2562).ความชุกของการติดเชื้อไวรัส Human papillomavirus (HPV) และไทป์ต่างๆ ในสตรีไทยที่มีผลแปปสเมียร์ปกติ. วารสารกรมวิทยาศาสตร์การแพทย์, 61(2), 73-85.

Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024).Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwidefor 36 cancers in 185 countries. CA: a cancer journal for clinicians, 74(3), 229-263.

Bowden, S. J., Doulgeraki, T., Bouras, E., Markozannes, G., Athanasiou, A., Grout-Smith, H., ... &Kyrgiou, M. (2023). Risk factors for human papillomavirus infection, cervical intraepithelialneoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies. BMC medicine, 21(1), 274.

Cronje, H. S. (2004). Screening for cervical cancer in developing countries. International Journal of Gynecology & Obstetrics, 84(2), 101-108.

Džundová, M. N., Sehnal, B., Zikán, M., Kocián, R., Dubová, O., Hubka, P., ... & Slama, J. (2023).Risk Factors for the Anal and Oral Human Papillomavirus (HPV) Infections among Women with Severe Cervical Lesions: A Prospective Case—Control Study. Biomedicines,

(12), 3183.

Giuliano, A. R., Lazcano-Ponce, E., Villa, L., Nolan, T., Marchant, C., Radley, D., ... & Barr, E. (2017). Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine. The Journal of infectious

diseases, 196(8), 1153-1162.

Gottschlich, A., Nuntadusit, T., Zarins, K. R., Hada, M., Chooson, N., Bilheem, S., ... & Meza, R. (2019). Barriers to cervical cancer screening and acceptability of HPV self-testing: a cross-sectional comparison between ethnic groups in Southern Thailand. BMJ open,

(11), e031957.

Hausen, H. Z. (2000). Papillomaviruses causing cancer: evasion from host-cell control in earlyevents in carcinogenesis. Journal of the National Cancer Institute, 92(9), 690-698.

Juntasopeepun, P., Davidson, P. M., Suwan, N., Phianmongkhol, Y., & Srisomboon, J. (2011).Human papillomavirus vaccination intention among young women in Thailand. Asian Pac J Cancer Prev, 12(12), 3213-3219.

Novak, E. (2007). Berek & Novak's gynecology. Lippincott Williams & Wilkins.Ong, S. K., Abe, S. K., Thilagaratnam, S., Haruyama, R., Pathak, R., Jayasekara, H., ... & Hwang, W. Y. (2023). Towardselimination of cervical cancer–human papillomavirus (HPV) vaccination and cervical

cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries.The Lancet Regional Health–Western Pacific, 39.

Partridge, E. E., Abu-Rustum, N. R., Campos, S. M., Fahey, P. J., Farmer, M., Garcia, R. L., ... & Wilczynski, S. (2010). Cervical cancer screening. Journal of the National ComprehensiveCancer Network, 8(12), 1358-1386.

Restaino, S., Pellecchia, G., Arcieri, M., Bogani, G., Taliento, C., Greco, P., ... & GynecologicOncology Group. (2024). Management for cervical cancer patients: A comparison of the guidelines from the international scientific societies (ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-

SEOM-ESMO-JSGO). Cancers, 16(14), 2541.

Sokolova, I., Algeciras-Schimnich, A., Song, M., Sitailo, S., Policht, F., Kipp, B. R., ... & Morrison, L. (2007). Chromosomal biomarkers for detection of human papillomavirus associatedgenomic instability in epithelial cells of cervical cytology specimens. The Journal of

Molecular Diagnostics, 9(5), 604-611.

Tesfaye, E., Kumbi, B., Mandefro, B., Hemba, Y., Prajapati, K. K., Singh, S. C., ... & Hajare, S. T.(2024). Prevalence of human papillomavirus infection and associated factors amongwomen attending cervical cancer screening in setting of Addis Ababa, Ethiopia. Scientific

Reports, 14(1), 4053.

Wongpratate, M., & Bumrungthai, S. (2024). Cervical cancer in Thailand: 2023 update. Obstetrics & Gynecology Science, 67(3), 261-269.

Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., ... & Muñoz, N. (2010). Human papillomavirus is a necessary cause of invasive cervical cancerworldwide. The Journal of pathology, 189(1), 12-19.

Ploysawang, P., Rojanamatin, J., Prapakorn, S., Jamsri, P., Pangmuang, P., Seeda, K., & Sangrajrang, S. (2021). National cervical cancer screening in Thailand. Asian Pacific Journal of Cancer Prevention: APJCP, 22(1), 25.

Termrungruanglert, W., Khemapech, N., Vasuratna, A., Havanond, P., Deebukkham, P., Kulkarni, A. S., & Pavelyev, A. (2021). The epidemiologic and economic impact of a quadrivalenthuman papillomavirus vaccine in Thailand. Plos one, 16(2), e0245894.

Downloads

Published

2026-01-16

How to Cite

1.
Pradittapong J. Epidemiological Distribution of High Risk Human Papillomavirus Genotype and Associated Factors of HPV Infection with Cervical cancer in The Female aged 30-60 Years at Roi-ET Province. Acad J Nurse Health Sci [internet]. 2026 Jan. 16 [cited 2026 Jan. 18];6(1):34-45. available from: https://he04.tci-thaijo.org/index.php/AJNHS/article/view/4165

Issue

Section

Research report